What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
It is not confirmed that ClinicalKey AI has full-text access to all 13 JAMA Network journals. Elsevier’s public individual-access page lists JAMA among curated journal abstracts, while describing full-text journal coverage separately. Its broader announcement of more than 130 full-text premium journals does not establish that the JAMA titles are included as full text.
What ClinicalKey AI’s public coverage information says
Elsevier describes ClinicalKey AI as a clinical decision-support service that draws on full-text content and abstracts. Its support documentation lists full-text journals and article abstracts among the content types, alongside society guidelines, reference books, Clinical Overviews, Drug Monographs, and publications from the FDA, CDC, and NLM. That general description does not identify the 13 JAMA Network journals as licensed full text. Elsevier’s product page and content-source information describe the service’s sources at a broader level.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Encyclopedia of Intensive Care Medicine, volume 1 to 4 | $1,615.00 | Buy on Amazon |
| 2 |
|
Geriatric Medicine: A Person Centered Evidence Based Approach | $499.99 | Buy on Amazon |
| 3 |
|
Encyclopedia of Primary Prevention and Health Promotion | $199.99 | Buy on Amazon |
| 4 |
|
Textbook of Palliative Care | $928.88 | Buy on Amazon |
| 5 |
|
Artificial Intelligence in Medicine (Volume 1 & 2) | $716.04 | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
On the individual-access page, Elsevier names “NEJM, BMJ, JAMA” among abstracts from a curated group of journals, with full-text journal articles described separately. That distinction matters: a JAMA abstract or citation appearing in results is not proof that ClinicalKey AI provides the complete article under its own license. Coverage and terms can change, so check the current page and your account’s entitlements. See Elsevier’s individual-access information.
Why the “more than 130 journals” announcement does not prove JAMA full-text access
In a February 18, 2026 announcement, Elsevier said ClinicalKey AI’s curated full-text premium journal collection had grown to more than 130 titles. The release named examples such as The Lancet series, NEJM, CHEST, JACI, JTO, and AJOG, but it did not establish full-text access to all 13 JAMA Network journals. The overall collection count should not be read as a JAMA-specific count or a statement of JAMA coverage. Read Elsevier’s announcement.
#1 Best Overall
What JAMA Network’s own access policies provide
JAMA Network identifies 13 journals and describes public-access policies that are separate from any ClinicalKey AI license. Accepted manuscripts may be deposited for release on publication. JAMA research becomes free online after six months, while research in specialty journals becomes free after 12 months. JAMA Network Open and JAMA Health Forum are fully open access; specialty journals also offer an open-access option. These publisher access routes do not establish that the same content is available as full text through ClinicalKey AI. JAMA Network’s access-policy page.
How to check what you can actually read
- Check the ClinicalKey AI coverage page. Look for the journal title and whether the result is identified as an abstract or full text; a citation or link alone does not indicate that Elsevier licenses the complete article.
- Open the article record. Confirm whether the full article text is displayed in ClinicalKey AI or whether the service shows only an abstract and a link elsewhere.
- Check your institution’s access separately. Elsevier says ClinicalKey AI can support link resolvers that connect users to institutional full-text holdings. That route may provide access through a library subscription, rather than through a ClinicalKey AI full-text license.
- Confirm your account entitlement. Availability can depend on whether access is individual or institutional, as well as the relevant subscription terms and coverage.
Who can use ClinicalKey AI and what to keep out of prompts
Elsevier’s personal digital subscription terms say ClinicalKey AI is intended for licensed medical practitioners and supervised students or residents. The terms restrict entry of US protected health information unless a user is accessing through a US institutional subscription and has verified an active Business Associate Agreement with Elsevier. Institutional terms may impose additional conditions; users should follow their organization’s rules. Review Elsevier’s subscription terms.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the product’s AI claims do—and do not—show
Elsevier describes conversational queries, cited responses, patient-context prompts, citation validation, and a proprietary knowledge base refreshed daily. These are product descriptions, not independent evidence that answers are clinically accurate or improve patient outcomes. Treat AI-generated output as a starting point for checking the cited literature and applicable clinical guidance, not as a substitute for professional judgment.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
